Male Breast Cancer Completed Phase 2 Trials for Imiquimod (DB00724)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00821964Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerTreatment